| Dr Mark Barry Abelson, MD | |
|
138 Haverhill St, Ste 104, Andover, MA 01810-1501 | |
| (978) 475-0705 | |
| (978) 475-0008 |
| Full Name | Dr Mark Barry Abelson |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Location | 138 Haverhill St, Andover, Massachusetts |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1811990682 | NPI | - | NPPES |
| 2035618 | Medicaid | MA | |
| M08808 | Other | MA | BLUECROSS/BLUESHIELD |
| 26176 | Other | MA | FALLON |
| 15823 | Other | MA | HARVARD PILGRIM HEALTHCAR |
| 037429 | Other | MA | TUFTS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | 37429 (Massachusetts) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Mark Barry Abelson, MD 138 Haverhill St, Ste 104, Andover, MA 01810-1501 Ph: (978) 475-0705 | Dr Mark Barry Abelson, MD 138 Haverhill St, Ste 104, Andover, MA 01810-1501 Ph: (978) 475-0705 |
News Archive
Increased vascular stiffness has been identified as an important part of hypertension in aging adults. Previous studies of aortic stiffness have focused on changes in structural proteins that alter the properties of vascular walls causing them to become rigid.
Dicom Systems have revealed that they will be unveiling the latest addition to the DCMSYS product family at the upcoming 2010 Annual HIMSS (Healthcare Information and Management Systems Society) Conference & Exhibition. This industry-driven conference is being held at the Georgia World Congress Center in Atlanta, GA, between March 1-4.
Older patients, minorities, and male patients are more likely to develop substernal thyroid goiters that are difficult to remove surgically, putting them at risk for treatment complications and death, say researchers in the January 6 online in the American Journal of Surgery.
A novel intraoperative bone wedge resection technique for Dwyer calcaneal osteotomy to correct calcaneal varus deformity is simple, accurate, and reproducible, restoring normal tibia calcaneal alignment, concludes a team of US investigators.
Genentech Inc., now part of Swiss drug developer Roche, and Biogen Idec Inc. on Sunday have announced positive and encouraging results from a clinical study of cancer drug Rituxan in patients with advanced type of non-Hodgkin's lymphoma. An estimated 65,540 people in the US were diagnosed with non-Hodgkin's lymphoma this year, and follicular lymphoma accounts for about 15 to 20 percent of those cases. The disease can occur at any time during adulthood, though people are typically diagnosed during their 50s and 60s.
› Verified 7 days ago
Dr. Gail L Torkildsen, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 138 Haverhill St, Suite 104, Andover, MA 01810 Phone: 978-475-0705 Fax: 978-475-0008 |